--2025/FY-- / 9.259B--
--2024/FY-- / 8.187B--
Mar 22, 20242023/FY7.703B / 8.380B--
Mar 23, 20232022/FY8.282B / 8.537B--
Mar 19, 20222021/FY8.254B / 9.065B--
CN Stock MarketDetailed Quotes
600422 KPC Pharmaceuticals, Inc.
- 16.17
- +0.54+3.45%
Market Closed Jan 6 15:00 CST
12.24BMarket Cap27.45P/E (TTM)
16.68High15.65Low175.33KlotVolume15.80Open15.63Pre Close284.48MTurnover2.32%Turnover Ratio27.55P/E (Static)756.98MShares23.9152wk High2.21P/B12.24BFloat Cap11.9252wk Low17.19Limit Up756.98MShs Float25.73Historical High14.07Limit Down6.59%Amplitude-0.59Historical Low0.20Dividend TTM16.23Avg Price81.16KlotAsk1.24%Div YieldTTM100Lot Size90.24KlotBid
KPC Pharmaceuticals, Inc. Key Stats
KPC Pharmaceuticals, Inc. Q3 2024 Earnings Date
Currency：CNYOct 26, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | -- | 1.90B | -- |
+3.41% | |||
| EPS | -- | 0.21 | -- |
-- |
Analyst Rating
Jan 6, 2025
KPC Pharmaceuticals, Inc. Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CNY
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
KPC Pharmaceuticals, Inc. Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
